US Stock MarketDetailed Quotes
MYNZ Mainz Biomed
- 0.336
- -0.018-5.14%
Close Jul 26 16:00 ET
- 0.340
- +0.004+1.25%
Pre 08:55 ET
7.35MMarket Cap-207P/E (TTM)
0.360High0.321Low1.21MVolume0.346Open0.354Pre Close406.12KTurnover6.58%Turnover RatioLossP/E (Static)21.89MShares4.38052wk High2.27P/B6.18MFloat Cap0.31552wk Low--Dividend TTM18.39MShs Float30.000Historical High--Div YieldTTM10.90%Amplitude0.315Historical Low0.335Avg Price1Lot Size
About Mainz Biomed Company
Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.
Company Profile
SymbolMYNZ
Company NameMainz Biomed
Listing DateNov 5, 2021
Issue Price5.00
Founded2021
CEOMr. Guido Baechler
MarketNASDAQ
Employees71
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressSirius Gutenberg Park,Robert Koch Strasse 50
CityMainz
ProvinceRheinland-Pfalz
CountryGermany
Zip Code55129
Phone49-6131-55428-60
Websitehttp://mainzbiomed.com
Company Executives
- Name
- Position
- Salary
- Guido Baechler
- Chief Executive Officer and Director
- --
- Philipp Freese
- Chief Business Officer
- --
- Dr. Frank Krieg-Schneider
- Chief Technology Officer
- --
- Dr. Chris von Toerne
- Chief Operating Officer
- --
- William J. Caragol
- Chief Financial Officer
- --
- Darin Leigh
- Chief Commercial Officer
- --
- Dr. Moritz Eidens
- Chief Scientific Officer and Director
- --
- Gregory J. Tibbitts
- Independent Director
- --
- Dr. Heiner Dreismann,PhD
- Independent Director
- --
- Dr. Alberto Libanori, PhD
- Independent Director
- --
- Nicole Holden
- Independent Director
- --
- Hans Hekland
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg